Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice

Bibliographic Information
Authors: Mahmoud N.R.; Younis A.I.; Zalat R.S.; Soliman A.S.A.; Khater M.M.
Journal: Journal of Parasitic Diseases
Publisher: Springer
Publication Date: 7 August 2024
Volume / Issue: Volume 48 / Issue 4
Pages: 849–859
ISSN: 9717196
DOI: 10.1007/s12639-024-01713-y
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Green Open Access
Authors and Affiliations
Mahmoud N.R., Medical Parasitology Department, Kasr Al-Ainy, Faculty of Medicine, Cairo University, Giza, Egypt; Younis A.I., Medical Parasitology Department, Kasr Al-Ainy, Faculty of Medicine, Cairo University, Giza, Egypt; Zalat R.S., Parasitology Department, Theodor Bilharz Research Institute, Giza, Imbaba, Egypt; Soliman A.S.A., Pathology Department, National Research Centre, Giza, Egypt; Khater M.M., Medical Parasitology Department, Kasr Al-Ainy, Faculty of Medicine, Cairo University, Giza, Egypt
Abstract
The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental Cryptosporidium parvum (C. parvum) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz Research Institute. Starting from the 7th day post infection (p.i), therapeutics were given to immunosuppressed infected mice, which were divided as follows; oral NTZ treated group (0.2 mg/g/day for 6 consecutive days), six-PRP-treated groups (0.5 μl/g/week) to be administered intravenously (IV) in 1st, 2nd, 3rd week as PRP alone in (3 groups) and combined with oral NTZ (0.2 mg/g/day for 6 consecutive days) in (3 groups). Parasitological, histopathological and immunohistochemical assessments of therapeutics under study were done. Fecal pellets collected from groups at different intervals were stained using modified Ziehl–Neelsen and examined under microscope. Among PRP-treated groups, the highest significant percentage of oocyst reduction (89.96%) was observed in the group received 3 doses of PRP in combination with NTZ on the 35th day post infection. Likewise, the histopathological examination of small intestinal tissue sections showed improvement in villous architecture with mild to moderate stunting and moderate inflammatory infiltrates in lamina propria. Immunohistochemical staining of small intestinal tissue sections showed moderate increase in the expression of TGF-β1. Therefore, PRP can be a novel strategy in the treatment of cryptosporidiosis particularly when combined with NTZ. © Indian Society for Parasitology 2024.
Keywords
Cryptosporidium parvum; Murine infection; Nitazoxanide; Platelet rich plasma; Transforming growth factor-β1; dexamethasone; transforming growth factor beta1; abscess; animal experiment; animal model; animal tissue; Article; cell infiltration; controlled study; cryptosporidiosis; hair loss; hematological parameters; histopathology; immunohistochemistry; immunosuppressive treatment; in vivo study; infection control; intestine tissue; lamina propria; male; mouse; nonhuman; oocyst; plasma cell; polymerase chain reaction; skin ulcer; sporozoite; stunting; thrombocyte rich plasma
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
